When should a mechanical tricuspid valve replacement be considered?

Slides:

Advertisements

Similar presentations

Transcatheter aortic valve replacement in patients with severe aortic stenosis who are at high risk for surgical complications: Summary assessment of.

Advertisements

Max B. Mitchell, MD The Journal of Thoracic and Cardiovascular Surgery

A 20-year experience with isolated pericardiectomy: Analysis of indications and outcomes Erin A. Gillaspie, MD, John M. Stulak, MD, Richard C. Daly,

Percutaneous aortic valves: Effective in inoperable patients, what price in high-risk patients? Lars G. Svensson, MD, PhD The Journal of Thoracic and.

When is the Ross operation a good option to treat aortic valve disease? Tirone E. David, MD, Anna Woo, MD, Susan Armstrong, MSc, Manjula Maganti, MSc

Harold M. Burkhart, MD, Jeffrey B. Riley, CCP, Sarah E

Long-term follow-up after aortic valve replacement with Edwards Prima Plus stentless bioprostheses in patients younger than 60 years of age Torsten Christ,

Anticoagulation early after mechanical valve replacement: Improved management with patient self-testing Jess L. Thompson, MD, Harold M. Burkhart, MD,

Intrinsic cardiac stem cells are essential for regeneration

Mitral Valve Repair Is Durable in Patients With Rheumatoid Arthritis

The incidence of vasoplegia in adult patients with right-sided congenital heart defects undergoing cardiac surgery and the correlation with serum vasopressin.

Abracadabra I, II…HeartMate 3?

Form ever follows function

Clinical and echocardiographic outcomes after repair of mitral valve bileaflet prolapse due to myxomatous disease Vincent Chan, MD, MPH, Marc Ruel, MD,

The use of vancomycin paste to reduce sternal wound infections after cardiac surgery— why is this still a “sticky” subject Harold L. Lazar, MD The Journal.

Quadruple valve replacement in patients with carcinoid heart disease

Long-term evaluation of biological versus mechanical prosthesis use at reoperative aortic valve replacement Vincent Chan, MD, MPH, B-Khanh Lam, MD, MPH,

Aditya K. Kaza, MD The Journal of Thoracic and Cardiovascular Surgery

Vikas Sharma, MBBS, Rakesh M. Suri, MD, DPhil, Joseph A

Surgical ablation for atrial fibrillation for two decades: Are the results of new techniques equivalent to the Cox maze III procedure? John M. Stulak,

Medical and surgical outcome of tricuspid regurgitation caused by flail leaflets David Messika-Zeitoun, MD, Helen Thomson, MD, Michael Bellamy, MD, Christopher.

Open aortic arch reconstruction after previous cardiac surgery: Outcomes of 168 consecutive operations Eduard Quintana, MD, FETCS, Pietro Bajona, MD,

The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery Vinay Badhwar, MD The Journal of Thoracic and.

It's not “just a shunt” but sometimes it should be…

Michele Gallo, MD, Gino Gerosa, MD

A first start for lung transplantation?

John M. Stulak, MD, Joseph A. Dearani, MD, Harold M

Surgery for aortic and mitral valve disease in the United States: A trend of change in surgical practice between 1998 and 2005 Scott D. Barnett, PhD,

Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD

Henry M. Spotnitz, MD, Daniel Y. Wang, MD

The Journal of Thoracic and Cardiovascular Surgery

Tirone E. David, MD, Gheorghe Gavra, MD, Christopher M

Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD

Niv Ad, MD, Lawrence M. Wei, MD

Minimally invasive tricuspid valve surgery in patients at high risk

The Journal of Thoracic and Cardiovascular Surgery

Bradley G. Leshnower, MD, Robert A. Guyton, MD, Richard J

Thirty-year experience with a bileaflet mechanical valve prosthesis

Mycobacterium chimaera: The ethical duty to disclose the minimal risk of infection to exposed patients Anita Nguyen, MBBS, C. Christopher Hook, MD, Joseph.

Commentary: Ongoing advancements in the understanding of tricuspid valve dynamics and functional geometry Daniel J.P. Burns, MD, MPhil The Journal of.

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Biomaterials for heart valve replacement: Conjectures and refutations

Functional tricuspid pathology: To treat or not to treat

Surgery for rheumatic tricuspid valve disease: A 30-year experience

Concomitant replacement of the ascending aorta is free—for some

The origins of open heart surgery at the University of Minnesota 1951 to 1956 Richard A. DeWall, MD The Journal of Thoracic and Cardiovascular Surgery

Mitral regurgitation surgery in patients with ischemic cardiomyopathy and ischemic mitral regurgitation: Factors that influence survival Simon Maltais,

Sameh M. Said, MD, Harold M. Burkhart, MD, Hartzell V

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

The future of cardiac surgery training: A survival guide

Apparently, size matters…in congenital heart disease and brain injury

Risk of recurrent gastrointestinal bleeding after aortic valve replacement in patients with Heyde syndrome Jess L. Thompson, MD, Hartzell V. Schaff,

The continuing challenge of congenital heart disease in China

Commentary: When a choice is not an echo

Ralph E. Delius, MD The Journal of Thoracic and Cardiovascular Surgery

Heidi Goerler, MD, Andre Simon, MD, Gregor Warnecke, MD, Anna L

The Robin Hood principle in the treatment of congenital heart disease: Taking technologic developments intended for adults and using it in kids Paul.

“The more things change…”: The challenges ahead

John M. Stulak, MD, Joseph A. Dearani, MD, Harold M

Appropriate Use Criteria for coronary revascularization in patients with stable ischemic heart disease: What the surgeon needs to know Harold L. Lazar,

First in line for robotic surgery: Would you want to know?

Respect the aorta The Journal of Thoracic and Cardiovascular Surgery

Relationship between left ventricular mass, wall thickness, and survival after subaortic septal myectomy for hypertrophic obstructive cardiomyopathy

Management of tricuspid regurgitation in congenital heart disease: Is survival better with valve repair? Sameh M. Said, MD, Joseph A. Dearani, MD, Harold.

Chordal replacement with polytetrafluoroethylene sutures for mitral valve repair: A 25- year experience Tirone E. David, MD, Susan Armstrong, MSc, Joan.

John M. Stulak, MD, Harold M. Burkhart, MD, Joseph A

Early and 1-year outcomes of aortic root surgery in patients with Marfan syndrome: A prospective, multicenter, comparative study Joseph S. Coselli, MD,

Which biologic valve should we select for the 45- to 65-year-old age group requiring aortic valve replacement? F. Dagenais, MD, P. Cartier, MD, P. Voisine,

Lessons learned from Melody valve retrieved at transplantation

Presentation transcript:

When should a mechanical tricuspid valve replacement be considered? Sameh M. Said, MD, Harold M. Burkhart, MD, Hartzell V. Schaff, MD, Jonathan N. Johnson, MD, Heidi M. Connolly, MD, Joseph A. Dearani, MD The Journal of Thoracic and Cardiovascular Surgery Volume 148, Issue 2, Pages 603-608 (August 2014) DOI: 10.1016/j.jtcvs.2013.09.043 Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Survival curves: A, overall survival; B, survival of those who underwent isolated TVR compared with the white population of Minnesota; C, overall survival of patients with Ebstein anomaly; D, overall survival of those with carcinoid heart disease. The Journal of Thoracic and Cardiovascular Surgery 2014 148, 603-608DOI: (10.1016/j.jtcvs.2013.09.043) Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Overall survival according to the type of the prosthesis. The Journal of Thoracic and Cardiovascular Surgery 2014 148, 603-608DOI: (10.1016/j.jtcvs.2013.09.043) Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions

Figure 3 Freedom from reoperation at 1, 5, and 10 years was 95.1%, 92.1%, and 92.1%, respectively. The Journal of Thoracic and Cardiovascular Surgery 2014 148, 603-608DOI: (10.1016/j.jtcvs.2013.09.043) Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions

Figure 4 Freedom from prosthetic mechanical thrombosis: A, overall; and B, based on the type of prosthesis. The Journal of Thoracic and Cardiovascular Surgery 2014 148, 603-608DOI: (10.1016/j.jtcvs.2013.09.043) Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions

Figure 5 A and B, Cardiac catheterization images showing the technique of percutaneous balloon valvuloplasty with thrombectomy for a thrombosed mechanical tricuspid valve (*). This procedure was performed in a patient who underwent spine surgery and his anticoagulation had to be held perioperatively, which resulted in thrombosis of the tricuspid valve prosthesis. A, White arrow indicates the catheter extending across the mechanical tricuspid valve (*); B, white arrowhead indicates balloon thrombectomy. The Journal of Thoracic and Cardiovascular Surgery 2014 148, 603-608DOI: (10.1016/j.jtcvs.2013.09.043) Copyright © 2014 The American Association for Thoracic Surgery Terms and Conditions